Maa: Yhdistynyt kuningaskunta
Kieli: englanti
Lähde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Diclofenac sodium
Kent Pharma (UK) Ltd
M01AB05
Diclofenac sodium
100mg
Suppository
Rectal
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100
_S423 LEAFLET Voltarol 20191203_ _ _ PATIENT INFORMATION LEAFLET VOLTAROL 100MG SUPPOSITORIES (diclofenac sodium) Your medicine is known as Voltarol 100mg suppositories but will be referred to as Voltarol Suppositories throughout the following patient information leaflet. Information for other strengths of Voltarol Suppositories i.e. 12.5mg, 25mg and 50mg also may be present in this leaflet. WHAT YOU NEED TO KNOW ABOUT VOLTAROL SUPPOSITORIES Your doctor has decided that you need this medicine to help treat your condition. PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TO USE THESE SUPPOSITORIES. IT CONTAINS IMPORTANT INFORMATION. Keep the leaflet in a safe place because you may want to read it again. If you have any other questions, or if there is something you don’t understand, please ask your doctor or pharmacist. This medicine has been prescribed for you. Never give it to someone else. It may not be the right medicine for them even if their symptoms seem to be the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Voltarol Suppositories are, and what they are used for 2. Things to consider before you start to use Voltarol Suppositories 3. How to use Voltarol Suppositories 4. Possible side effects 5. How to store Voltarol Suppositories 6. Further information 1. WHAT VOLTAROL SUPPOSITORIES ARE AND WHAT THEY ARE USED FOR Diclofenac sodium, the active ingredient in Voltarol Suppositories, is one of a group of medicines called non-steroidal anti ‑ inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation. Voltarol Suppositories relieve pain, reduce swelling and ease inflammation in conditions affecting the joints, muscles and tendons including: – Rheumatoid arthritis, osteoarthritis, acute gout, ankylosing spondylitis – Backache, sprains and strains, soft tissue sports injuries, frozen shoulder, dislocations and fractures – Tendonitis, tenosynovitis, bu Lue koko asiakirja
PRODUCT SUMMARY 1. Trade Name of the Medicinal Product Not applicable 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Not applicable 3. PHARMACEUTICAL FORM Not applicable CLINICAL PARTICULARS 4.1. Therapeutic Indications Not applicable 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Not applicable 4.3. CONTRA-INDICATIONS Not applicable 4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE Not applicable 4.5. INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION Not applicable 4.6. PREGNANCY AND LACTATION Not applicable 4.7. EFFECTS ON ABILITY TO DRIVE AND USE MACHINES Not applicable 4.8. UNDESIRABLE EFFECTS Not applicable 4.9. OVERDOSE Not applicable PHARMACOLOGICAL PROPERTIES 5.1. Pharmacodynamic Properties Not applicable 5.2. PHARMACOKINETIC PROPERTIES Not applicable 5.3. PRECLINICAL SAFETY DATA Not applicable PHARMACEUTICAL PARTICULARS 6.1. List of Excipients Not applicable 6.2. INCOMPATIBILITIES Not applicable 6.3. SHELF LIFE Not applicable 6.4. SPECIAL PRECAUTIONS FOR STORAGE Not applicable 6.5. NATURE AND CONTENTS OF CONTAINER Not applicable 6.6. INSTRUCTION FOR USE/HANDLING Not applicable ADMINISTRATIVE DATA 7. Marketing Authorisation Holder Not applicable 8. MARKETING AUTHORIZATION NUMBER Not applicable 9. DATE OF FIRST AUTHORISATION/RENEWAL OF AUTHORISATION Not applicable 10. DATE OF (PARTIAL) REVISION OF THE TEXT Not applicable Lue koko asiakirja